Skip to main content
. Author manuscript; available in PMC: 2010 Feb 10.
Published in final edited form as: Nat Neurosci. 2002 Nov;5(11):1242–1247. doi: 10.1038/nn958

Table 2.

Demographic and clinical characteristics of PTSD and non-PTSD twin pairs.

PTSD Non-PTSD Two-factor ANOVA

Exposed
(n = 17)
Unexposed
(n = 17)
Exposed
(n = 23)
Unexposed
(n = 23)
Diagnosis Exposure Interaction
F1,76 P F1,76 P F1,76 P
Age (years) 53.1 (3.3) 53.1 (3.3) 51.8 (2.3) 51.8 (2.3) 3.8 0.05 - - - -
Education (years) 13.5 (2.6) 14.3 (2.8) 14.7 (2.4) 14.7 (2.6) 1.8 0.18 0.45 0.51 0.55 0.46
MAST* 20.2 (17.6) 6.8 (10.4) 2.4 (4.5) 2.5 (4.0) 22.8 <0.001 8.4 0.005 8.5 0.005
Non-combat trauma (number of events) 7.9 (2.6) 5.3 (3.8) 5.1 (4.0) 4.2 (3.0) 6.1 0.02 4.9 .03 1.3 0.26
Combat severity 7.9 (1.9) - 3.5 (2.6) - 67.4 <0.001 - - - -
CAPS 72.2 (16.6) - 6.2 (7.3) - 577.7 <0.001 - - - -

Data given as mean (s.d.).

*

Michigan Alcoholism Screening Test. Data is missing for one PTSD pair and two non-PTSD pairs. Follow-up t-tests: ExP+ versus ExP−, t37 = 4.63, P < 0.0001; UxP+ versus UxP−, t35 = 1.70, P = 0.09; ExP+ versus UxP+, t15 = 2.92, P = 0.01; ExP− versus UxP−, t20 = 0.14, P = 0.89.

Lifetime number of non-combat potentially traumatic events. Data is missing for one PTSD pair and two non-PTSD pairs. Follow-up t-tests: ExP+ versus ExP−, t37 = 2.51, P = 0.02; UxP+ versus UxP−, t36 = 0.96, P = 0.34; ExP+ versus UxP+, t15 = 2.51, P = 0.02; ExP− versus UxP, t20 = 0.64, P = 0.53.

Clinician-Administered PTSD Scale (total symptom score)